Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study

Hepatitis A is a vaccine-preventable infection caused by the HA virus (HAV) with transitional to intermediate endemicity in China. An inactivated vaccine first licensed in China in 2010 (Avaxim® 80U Pediatric) is indicated for primary and booster vaccination in children from 12 months to 15 years of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Nianmin, Rasuli, Anvar, Thollot, Yaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605741/
https://www.ncbi.nlm.nih.gov/pubmed/30403910
http://dx.doi.org/10.1080/21645515.2018.1539600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605741/
https://www.ncbi.nlm.nih.gov/pubmed/30403910
http://dx.doi.org/10.1080/21645515.2018.1539600

Ejemplares similares